Lalla M, Vesikari T, Virolainen M
Clin Exp Immunol. 1973 Oct;15(2):193-202.
Twenty-eight sero-negative young women were vaccinated with RA 27/3 or HPV-77/DE5 strain live attenuated rubella vaccine. Haemagglutination-inhibiting antibody developed in all but one of the subjects. Rubella-specific IgM antibodies were demonstrable 3–6 weeks after vaccination. Complement-fixing and platelet-aggregation antibodies were more often detectable after RA 27/3 than after HPV-77/DE5 vaccination. After vaccination the blood lymphoblast count increased with a peak at 2 weeks. In one subject no humoral antibody response was detectable but even in this case there was a lymphoblast response. A marked increase in blasts was detected in a single case of natural rubella infection. In the vaccinated subjects the tuberculin skin test did not reveal suppression of delayed hypersensitivity 3 weeks after vaccination, nor was there a change in the responsiveness of lymphocytes to PHA 2 weeks after vaccination. No significant decrease in platelet count was seen in any of the subjects.
28名血清学阴性的年轻女性接种了RA 27/3或HPV - 77/DE5株风疹减毒活疫苗。除1名受试者外,其他所有受试者均产生了血凝抑制抗体。接种疫苗后3 - 6周可检测到风疹特异性IgM抗体。与接种HPV - 77/DE5疫苗相比,接种RA 27/3疫苗后更常检测到补体结合抗体和血小板聚集抗体。接种疫苗后,血液淋巴细胞计数增加,在2周时达到峰值。有1名受试者未检测到体液抗体反应,但即便如此,该受试者仍有淋巴细胞反应。在1例自然感染风疹的病例中检测到原始细胞显著增加。在接种疫苗的受试者中,接种疫苗3周后结核菌素皮肤试验未显示迟发型超敏反应受到抑制,接种疫苗2周后淋巴细胞对PHA的反应性也未发生变化。所有受试者的血小板计数均未出现显著下降。